{"paper_id":"2ef8db08-2e78-401c-8790-eba25a5676f4","body_text":"1 A toxin/antitoxin system targeting the replication sliding-clamp \n2 induces competence in Streptococcus pneumoniae.\n3  Maziero Mickaël 1, 2 , Juillot Dimitri 3, Mortier-Barrière Isabelle 1, 2 , Carballido-Lopez Rut 3, \n4 Campo Nathalie 1, 2 , Genevaux Pierre 1, 2 , Bordes Patricia 1, 2 , Patrice Polard 1, 2 * and Mathieu \n5 Bergé1, 2*.\n6 1 Laboratoire de Microbiologie et Génétique Moléculaires (LMGM), Centre de Biologie \n7 Intégrative (CBI), CNRS, Toulouse, France.\n8 2 Université de Toulouse, Toulouse, France.\n9 3 Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, 78350, Jouy-en-Josas, France\n10 *Corresponding authors\n11 Abstract: \n12 Streptococcus pneumoniae is a pathogenic bacterium capable of entering a cellular \n13 differentiation state, called competence, which enables it to acquire new genetic functions by \n14 natural transformation, as well as physiological functions such as tolerance to a number of \n15 antibiotics. The transition to this state is regulated by various environmental or intracellular \n16 signals that converge on the comCDE operon, which groups together the competence \n17 initiation genes. A fraction of activated cells is sufficient to propagate competence to the \n18 whole population via the product of the comC gene, the competence stimulating peptide \n19 (CSP). Remarkably, depletion of the essential ClpX/ ClpP AAA+ protease has been shown to \n20 induce the comCDE operon.\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n21 Here we demonstrate that the ClpX-dependent induction of competence relies on the Spr1630 \n22 toxin (RipA), part of a Rosmer toxin-antitoxin system. We show that this toxin generates \n23 replicative stress by acting on the sliding clamp of replication, inducing transcription of the \n24 comCDE operon. Bacteria that produce RipA appear to lose their viability but remain \n25 metabolically active and able to produce CSP, thereby transferring competence to viable \n26 neighbouring cells.\n27 Authors’ summary:\n28 The environment in which bacteria live puts them under a great deal of stress, forcing them \n29 to adapt constantly, either temporarily or permanently. Streptococcus pneumoniae , a \n30 pathogenic bacterium implicated in various pathologies such as otitis, meningitis and \n31 pneumonia, is also subject to stress, whether from its host, antibiotic treatments or the \n32 microbiota in which it lives. In response to this, S. pneumoniae is able to switch to a \n33 differentiated state called competence. This allows it to acquire new genetic characteristics \n34 through natural transformation, but also to better tolerate stresses such as antibiotics \n35 pressure.\n36 The underlying signals and signaling pathways of this phenotypic switch remain poorly \n37 characterized. In this study, we identified a novel toxin–antitoxin system that, when activated, \n38 causes a subset of the population to self-sacrifice by disrupting its own DNA replication. This \n39 self-induced arrest serves as a signal that promotes the transition to competence in \n40 neighboring cells, thereby improving the capacity for adaptation at the populational level. \n41\n42\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n43 Introduction:\n44 Streptococcus pneumoniae is a commensal bacterium of the human nasopharynx, but can \n45 become an invasive or non-invasive pathogen leading to a wide range of diseases such as \n46 otitis, pneumonia, meningitis [1,2]. The emergence of antibiotic resistance in S. pneumoniae \n47 is making treatment more complex, and led to the deaths of around 600,000 people in 2019 \n48 [3]. This is one of the reasons why S. pneumoniae was ranked among the 12 priority pathogens \n49 by the World Health Organization in 2017. Several studies have strongly suggested that the \n50 emergence and rapid spread of antibiotic resistance is due to the ability of S. pneumoniae to \n51 undergo natural transformation [4].\n52 Natural transformation is a horizontal gene transfer mechanism that enables bacteria to \n53 capture exogenous DNA and integrate it into their chromosomes through homologous \n54 recombination. First identified in S. pneumoniae [5,6], then in a wide range of bacteria, this \n55 mechanism has been relatively well characterized at the molecular level in a variety of bacteria \n56 [7–9]. In S. pneumoniae, most of the proteins required for natural transformation are only \n57 expressed during a period when the bacterium enters a particular physiological state called \n58 competence. The induction of competence is regulated by the level of transcription of two \n59 operons, comCDE and comAB. The comC gene encodes for a peptide [10] which is exported \n60 and matured by the ABC-transporter ComAB; the externalized product is called Competence \n61 Stimulating Peptide (CSP). CSP is able to activate the ComDE two component system [11]. In \n62 turn, phosphorylated ComE activates transcription of the comAB and comCDE operons as part \n63 of the early competence regulon, inducing an autocatalytic loop [11,12]. Two waves of genes \n64 are then successively induced: late and delayed competence genes [13,14], resulting in ~14% \n65 of the transcriptome being modified during competence.\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n66 The transition to competence is initially an individual behavior and when a sufficient fraction \n67 of the population has reached competence, the entire population is converted to competence \n68 following transmission of CSP via cell contact [15] by the self-inducing fraction [16]. The time \n69 required for this inductive fraction to appear is highly dependent on the stimuli received \n70 individually by the cells, which will affect the transcription of the early comCDE operon. \n71 Several stresses are known to promote competence, such as drugs that alter replication or \n72 genome integrity [17–19], temperature [20,21] and ribosome decoding [22]. At least two \n73 transduction pathways from these signals to comCDE have been described [20], but it is clear \n74 that not all pathways have been identified, and those that have remain poorly characterized. \n75 Early on in the molecular characterization of competence, it was noted that ClpP appeared to \n76 repress its development [23]. The clpP gene encodes the proteolytic subunit that forms the \n77 Clp ATP-dependent protease complex, together with an ATPase subunit ClpC, ClpE, ClpL, or \n78 ClpX. Systematic CRISPRi (clustered regularly interspaced short palindromic repeats \n79 interference) of clpP or any of the genes encoding the ATPase subunits demonstrated that \n80 only depletion of ClpP or ClpX induced competence development [24]. It was logically \n81 proposed that ClpX is the main ATPase implicated with ClpP to repress competence. \n82 Interestingly, ClpX is the only ATPase subunit of the ClpP complex that is essential for S. \n83 pneumoniae viability [25]. The essentiality of clpX was shown to be due to the presence of the \n84 gene spr1630 which is proposed to encode the toxin of a so far uncharacterized toxin-antitoxin \n85 (TA) system [26].\n86 The aim of the present work was to characterize the molecular pathway inducing competence \n87 under the control of ClpXP. Using genetic approaches, we demonstrated that competence \n88 induction by depletion of ClpX but not ClpP is dependent on spr1630. We demonstrated that \n89 Spr1630 is able to induce competence alone. We experimentally demonstrated that Spr1629 \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n90 antagonizes the effects of Spr1630 leading us to propose that Spr1630 and Spr1629 form a \n91 toxin-antitoxin system (TA) that belongs to the large Rosmer TA family. Furthermore, our data \n92 strongly suggest that Spr1630 targets DnaN, the sliding clamp in DNA replication, and as such \n93 we propose to rename this TA system RipAB (Replication Interfering Protein). Finally, we place \n94 the impact of this TA system in the population context of the onset of competence and show \n95 that production of the RipA toxin gives rise to an inducing fraction that acts as a group of \n96 sentinels that warn the rest of the population of a stress by propagating competence \n97 development.\n98 Results:\n99 Competence induction by clpX depletion is RipA-dependent.\n100 We first sought to reproduce the induction of competence by transcriptional depletion of clpX \n101 or clpP as described previously [23,24]. To monitor the development of competence, we used \n102 a transcriptional fusion of the comCDE early operon promoter with the luciferase gene as a \n103 reporter [17,27]. We then constructed strains carrying constructions that allow Clustered \n104 Regularly Interspaced Short Palindromic Repeats interference (CRISPRi) in S. pneumoniae [24]. \n105 Briefly, the defective Streptococcus pyogenes Cas9 (dCas9) controlled by an IPTG-dependent \n106 promoter was integrated into the S. pneumoniae chromosome together with the lacI gene and \n107 a single-guide RNA (sgRNA), targeting clpX or clpP, under the control of constitutive promoters \n108 [24]. When these cells were cultured in an unfavourable environment for the spontaneous \n109 development of competence (pH 7.0), no changes in the transcription of the comCDE operon \n110 were observed (Fig 1A, black lines). The addition of IPTG induced a strong increase in luciferase \n111 production reflecting the induction of transcription of the comCDE operon in either ClpX and \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n112 ClpP depletion (Fig 1A, red lines), suggesting that the depletion of ClpX or ClpP is a competence \n113 trigger, as previously published [24]. Notably, the increase of comCDE transcription was \n114 concomitant with a reduction in growth, which reports on the depletion of the Clp proteins. \n115 Since the biological essentiality of ClpX has previously been linked to the ripA gene [26], we \n116 explored the possibility that RipA is also involved in triggering competence. As expected, \n117 deletion of ripA significantly improved growth of ClpX depleted cultures (Fig 1B). Importantly, \n118 competence induction was completely abolished in the ClpX depleted culture lacking ripA (Fig \n119 1B, top left panel), indicating that competence depends solely on RipA when ClpX is depleted. \n120 In an interesting way, and in contrast to the ClpX depletion background, ClpP depletion was \n121 still able to trigger competence in the ripA null mutant strain (Fig 1B, top right panel ), \n122 suggesting that ClpP dependent induction of competence is not functionally related to RipA. \n123 However, as the absence of ripA consistently enhanced growth of the ClpP-depleted strain \n124 (Fig 1B, bottom right panel), we cannot rule out the involvement of ClpP in RipA toxicity \n125 management. Altogether, these results confirmed the link between ClpX and RipA, and \n126 revealed a ClpX-dependent role of RipA in competence induction.\n127 The RipA toxin induces competence and is antagonized by the RipB antitoxin.\n128 To test the ability of RipA to induce competence, we produced the protein under the control \n129 of an IPTG inducible promoter [28]. To ensure tight repression of the IPTG-sensitive promoter, \n130 a second copy of the lacI gene driven by the constitutive PF6 promoter was integrated into \n131 the S. pneumoniae chromosome [24]. As ripA is part of an operon together with the essential \n132 ripB gene (spr1629) (Fig 2A), we also constructed strains containing the whole operon or ripB \n133 alone under IPTG induction. Fig 2B shows that expression of ripA induces competence \n134 development in an IPTG-dependent manner whereas ripB expression does not. Interestingly, \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n135 expression of the ripAB operon does not lead to competence development either, suggesting \n136 that ripB expression inhibits the action of RipA. We also note that ripA expression alone causes \n137 growth retardation in correlation with IPTG concentration and again co-expression of ripB \n138 impairs this growth defect (Fig 2B). We confirmed this by assessing the growth capacity of \n139 these strains on agarose medium in presence of increasing IPTG concentrations (Fig 3AB). \n140 From 10 µM IPTG, the strain expressing only ripA began to lose viability. Growth ability was \n141 almost completely lost from 20 µM IPTG. Production of ripB in operon with ripA completely \n142 cancelled out this toxicity. To test whether RipB could exert its protective effect in trans, we \n143 expressed ripA and ripB under IPTG inducible promoters, but at two different chromosomal \n144 loci. In this condition, RipB again antagonised the effect of RipA (Fig 3C). These results are \n145 consistent with the idea that RipA and RipB form a TA system as previously proposed [26]. We \n146 next tested whether RipA could be responsible for the previously observed essential nature \n147 of ripB [29] by attempting to delete ripB in different genetic backgrounds. Transformation \n148 results shown in Fig 3D demonstrate that ripB deletion could be obtained only when ripA was \n149 absent, further supporting that RipAB is a bona fide TA system in S. pneumoniae. Since RipA is \n150 responsible for the essentiality of both clpX [26] and ripB in S. pneumoniae, these data suggest \n151 that both proteins are controlling RipA activity.\n152 Suppressor mutations in dnaN antagonize RipA toxicity\n153 In search for RipA potential target(s), we took advantage of a S. pneumoniae interactome \n154 study based on yeast two-hybrid (Y2H) approach, which suggests that RipA interacts with \n155 DnaN [30]. As DnaN encodes the sliding clamp, an essential element in DNA replication, we \n156 considered that DnaN could be the target of RipA. To test this hypothesis, we searched for \n157 genetic suppressors of RipA toxicity in the dnaN locus. To this end, the strain producing RipA \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n158 under the control of an IPTG-inducible promoter was transformed by error-prone ~ 4kb PCR \n159 fragments centred on the dnaN locus and plated on agar medium supplemented with 20 µM \n160 IPTG. Interestingly, transformation with error-prone dnaN PCR fragments resulted in a higher \n161 number of colonies (about tenfold) compared to non-transformed control cells (Fig 4A). \n162 Sequencing the 4kb dnaN region of these transformants revealed that all mutations were \n163 located in the dnaN gene (Fig 4B). Seven strains with single mutations were obtained, leading \n164 to seven different amino acid substitutions affecting 5 different residues of DnaN (H183, L185, \n165 Y249, Y333, L371). Remarkably, these five residues are clustered in the same region of the \n166 DnaN structure (Fig 4B), a hydrophobic pocket implicated in DnaN protein-protein interactions \n167 [31]. We then characterized the ability of these mutations to suppress the toxicity linked to \n168 increased production of RipA (Fig 4C). We found that, the majority of the mutations allow \n169 significant growth at IPTG concentrations similar to the chosen selection threshold (20 µM \n170 IPTG). Beyond this concentration, their effect diminishes drastically as ripA transcription \n171 increases. However, two mutations (Y249N) and (Y333H) enable growth at the highest IPTG \n172 concentration tested (200µM IPTG). This suggests that the various mutations do not exhibit \n173 the same ability to prevent toxicity of RipA. We have therefore categorised them as strong \n174 (Y249N, Y333H), intermediate (L185R) or weak (H183Q, H183L, H183P, L371F) suppressors. \n175 DnaN substitutions impair DnaN-RipA interaction in yeast two-hybrid assay.\n176 Since RipA interacts with DnaN in yeast two-hybrid assays (Y2H) [30], we investigated whether \n177 the single nucleotide polymorphism suppressive mutations in dnaN alter this interaction. We \n178 decided to test this interaction with one of the strongest suppressive mutations (Y249N), as \n179 well as a representative of the weaker mutations (H183P), and a mutation that displays an \n180 intermediate suppressive phenotype (L185R). First, we detected an interaction between DnaN \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n181 with itself as expected, but also for RipA with itself, suggesting a potential dimerization of the \n182 protein RipA (Fig 5A). We also reproduced the Y2H interaction between RipA and DnaN in both \n183 directions of interactions. However the RipA:DnaN interaction was completely abolished \n184 whatever the suppressive mutation analysed, (Fig 5B) suggesting a loss or reduction of \n185 physical interaction between RipA and DnaN proteins that express suppressive mutations. \n186 Together, these data suggest that RipA targets DnaN through a physical interaction.\n187 DnaN substitutions impair competence development mediated by RipA.\n188 We next investigated whether the interaction between RipA and DnaN was responsible for \n189 the induction of competence in cells overexpressing RipA. To answer this, we tested the \n190 induction of competence in strains carrying the three categories of suppressive mutations \n191 described above. All strains carrying a suppressive mutation showed better growth in liquid \n192 medium compared to the reference strain in IPTG+ conditions (Fig 6A). Mutant strains \n193 displayed a gradation in the suppressive effect of the toxicity, as observed in spot test assays \n194 (Fig 4C). Thus, the strain carrying the most effective suppressive mutation (DnaNY249R) did not \n195 show any growth problems whatever the IPTG concentration. Conversely, the weakest \n196 suppressor mutant (DnaN H183P) remained quite strongly impacted at the highest RipA \n197 production level. The DnaNL185R mutant exhibited an intermediate growth behaviour (Fig 6A). \n198 Overall, competence induction of the mutant strains was strikingly impaired compared to the \n199 WT reference strain (Fig 6A). However, enlarging the comCDE transcription observation scale \n200 by a logarithm (Fig 6B) revealed a gradation in behaviour during the development of \n201 competence in the three representative mutant strains. Indeed, DnaN Y249R never induced \n202 competence whatever the concentration of IPTG whereas, DnaN H183P and DnaN L185R strains \n203 only displayed a residual competence burst at high ITPG concentration (Fig 6B). It is interesting \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n204 to note that the ability to trigger competence appears inversely proportional to the \n205 categorisation proposed to describe the ability to withstand the toxicity of RipA.\n206 “Doomed cells” are able to promote competence of naive cells.\n207 All the above elements support a link between the toxicity of RipA and its ability to induce \n208 competence. To test this, we compared the toxicity and competence induction kinetics. When \n209 RipA-producing cells were observed by microscopy, it was clear that bacterial multiplication \n210 was affected after 90 minutes of IPTG exposition, but that cell integrity was maintained for 30 \n211 additional minutes (Fig 7A). To complete this observation, we evaluated the ability of the same \n212 culture to generate colonies on IPTG-free agarose medium after different RipA exposure \n213 duration. Fig 7B shows that most cells were unable to generate colonies after 45 minutes of \n214 exposure. However, as competence development occurred after about 120 minutes of RipA \n215 toxicity exposure (Fig 2B), we wondered about the physical state of these cells. To test \n216 whether these cells are physiologically active, at least regarding competence regulation, we \n217 incubated RipA-producing cells under the control of IPTG for more than 60 minutes, with \n218 synthetic CSP to trigger rapid competence induction in the culture. These cells carrying the \n219 comC::luc reporter gene were still able to respond to CSP at a higher level than unstressed \n220 cells that did not produce RipA (Fig 7C). We then tested if RipA-exposed cells were also able \n221 to produce enough CSP to propagate competence to naive cells. For this, we grew a strain \n222 expressing ripA under IPTG promoter but lacking the comC::luc reporter for 120 minutes in \n223 medium containing IPTG to allow induction of RipA-mediated competence. As a negative \n224 control, we also used a strain with the same background, but unable to produce CSP (comC0 \n225 strain). After the allotted time, these cells were mixed (1:1 ratio) with naive wild-type cells \n226 carrying the comC::luc reporter (strain R825). Almost instantaneously, wild-type cells switched \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n227 to competence when mixed with RipA stressed cells capable of producing CSP, whereas no \n228 change was observed for wild-type cells alone or mixed with comC0 cells (Fig 7D). These \n229 observations were complemented by measuring the ability of strain R825 to transform. Under \n230 these conditions, transformation can only occur in the presence of cells that produce ripA and \n231 are capable of producing CSP (Fig 7D, bottom panel). Altogether these results show that the \n232 RipA-producing cells, although rapidly losing their viability, remain metabolically active and \n233 produce sufficient CSP to propagate the competence to naive cells and promote their ability \n234 to transform.\n235 Discussion:\n236 ClpX and ClpP use independent pathways to repress competence. \n237 We found that the RipA toxin is responsible for the induction of competence generated by \n238 ClpX depletion but not ClpP depletion. Since deletion of ripA slightly improves the growth of a \n239 clpP strain, it is not possible to exclude the possibility of a partial link between RipA and ClpP, \n240 but ClpP-mediated induction of competence appears to be almost independent of RipA. It is \n241 very likely that ClpP, in association with other accessory proteins like ClpE and ClpC, ensures \n242 the homeostasis of several competence-regulating proteins, such as ComX or ComW \n243 respectively as previously demonstrated [32] or hypothesized, such as ComE [23]. Liu et al., \n244 demonstrated that among the ClpP accessory proteins, only depletion of ClpX by CRISPRi was \n245 capable of inducing competence [24]. However, it should be kept in mind that the intensity of \n246 protein depletion generated by CRISPRi can be extremely variable from one gene to another \n247 or from one guide to another [33]. In addition, the quantity of accessory proteins required to \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n248 ensure repression of competence can also be extremely variable depending on the protein. \n249 Understanding the role of ClpP in competence repression will require further investigation.\n250 How are RipA, RipB and ClpX related?\n251 As ripA is responsible for clpX essentiality, it has already been hypothesised that RipA is a toxin \n252 that is impaired in its activity by ClpX [26]. We have furthermore shown here that the essential \n253 nature of RipB is also linked to the presence of RipA. The C-terminus of RipB protein shares \n254 homology with ImmA, a Zn metalloprotease involved in regulation of excision and transfer of \n255 the mobile genetic element ICEBs1 [34,35]. The N-terminus contains a transcriptional \n256 regulator domain of the XRE-family, sharing homology with the HipB antitoxin. As ectopic \n257 expression of ripA was impaired by trans-expression of ripB, it is reasonable to suggest that \n258 RipB acts as an antitoxin and that RipAB belongs to the large Rosmer TA family [36]. However, \n259 the RipAB system is not autonomous, since the action of RipB is strictly dependant on clpX \n260 integrity. This could be explained by different mechanisms. Firstly, we could assume that ClpX \n261 somehow modulates the toxin/antitoxin activation cycle. The involvement of ClpX in \n262 managing the function of a toxin-antitoxin system has already been reported, but until now \n263 its role has been described as activating the degradation of the antitoxin and therefore \n264 releasing the toxin [37–39]. In this work, ClpX plays a negative role in the action of the toxin. \n265 Other more indirect relationships might also be involved, for example, in a ClpX-deficient \n266 genetic context, DnaN appeared to be more sensitive to the action of RipA.\n267 The DnaN sliding clamp is a target of RipA\n268 Given that RipA toxicity can be counteracted by mutations in the DnaN gene and that the same \n269 mutations abolish the Y2H interaction between RipA and DnaN, it is reasonable to propose \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n270 that the sliding clamp is the target of RipA. The most obvious molecular action would be that \n271 RipA affects the main action of the sliding clamp, by disrupting DNA replication. Replicative \n272 stresses are clearly known to be factors that induce competence [16,17,19,40], which is in line \n273 with our results showing that RipA production induces competence and that suppressive \n274 mutations in dnaN strongly antagonise it. However, we cannot rule out the hypothesis that \n275 DnaN is an intermediate target of RipA and that its final target would be a partner of the sliding \n276 clamp. DnaN is known to act as a hub for interactions between different proteins such as MutL \n277 and MutS, DNA polymerases or ligases [41]. The majority of these interactions occur via a \n278 hydrophobic pocket localized on the anti-Pol face of the sliding Clamp [31]. All the suppressive \n279 mutations uncovered in this work are localized in the hydrophobic pocket close to the \n280 interaction zone. It is therefore conceivable that RipA disrupts the dynamics of the sliding \n281 clamp interactome, thereby inducing perturbations in the replicative machinery.\n282 Biological role of RipA in S. pneumoniae\n283 Several TA systems affecting replication have been discovered mostly affecting \n284 topoisomerases [42,43], but very few directly affect the sliding-clamp [44]. For example, SocB, \n285 the toxin of the SocAB type VI TA, was the first toxin described to target the sliding-clamp in \n286 Caulobacter crescentus [45]. The discovery of its target was also achieved using genetic \n287 approaches. The mutations suppressing the action of SocB were located in the same \n288 hydrophobic pocket of the sliding clamp as the one supressing RipA toxicity. In addition, it is \n289 interesting to note that SocB induces the SOS response system by altering replication in C. \n290 crescentus; while in S. pneumoniae, a bacterium lacking an SOS response system [45], ripA \n291 expression induces the development of competence, a physiological state frequently \n292 proposed as a replacement for the SOS system [19,40,46,47]. However, consultation of \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n293 alignment tools did not reveal any sequence or structural homology between SocB and RipA, \n294 nor between their respective antitoxins (https://www.rcsb.org/alignment). Taken together, \n295 these elements suggest a functional convergence of these TA systems towards a central target \n296 of the cell cycle.\n297 However, one notable difference needs to be highlighted: while the induction of the SOS \n298 system remains an individual behaviour, the induction of competence leads to a population \n299 behaviour. In fact, it is well established that certain replicative stresses induce competence in \n300 S. pneumoniae and in this way, a fraction of the population subjected to RipA stress could \n301 transmit this signal through the production of CSP to the whole of the unstressed population, \n302 through a potential sacrificial behaviour (Fig 8). In the end, the switch to competence allows \n303 the generation of a heterogeneous population, both physiologically and genetically, allowing \n304 the emergence of potentially better adapted individuals [16]. The fate of the inducer cells is \n305 of particular interest, as it will provide clues as to the biological signals that activate RipA. \n306 Indeed, the transition of these cells to a stasis state could be consistent with the ability of \n307 antibiotics to induce competence [17]. In such a model, stressed cells that activate RipA trigger \n308 two mechanisms that allow them to transition to a potentially persistent state while enabling \n309 other cells to become competent. This could be relevant, given that competence enables the \n310 population to tolerate certain antibiotics more effectively [16]. Alternatively, sacrificial \n311 behaviour could limit the spread of danger while warning neighbouring cells of potential \n312 stress. This behaviour is reminiscent of phage resistance mechanisms, in which TA systems are \n313 involved [44,48]. This suggests that we should explore the possibility of a previously unknown \n314 link between competence and phages in S. pneumoniae.\n315 Material and methods:\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n316 Strains and growth media.\n317 All S. pneumoniae strains used were derived from R800 strain [49] and are listed in the \n318 supporting tables file.\n319 Standard procedures for transformation and growth media were used [50]. Briefly, pre-\n320 competent cells were treated at 37°C for 10 min with synthetic CSP1 (100ng mL −1) to induce \n321 competence, then exposed to transforming DNA for 20 min at 30°C. Transformants were then \n322 plated on CAT agar supplemented with 4% horse blood and incubated for 120min at 37°C. \n323 Transformants were then selected by addition of a second layer of agar medium containing \n324 the appropriate antibiotic and incubated overnight at 37°C. Antibiotic concentrations (µg mL–\n325 1) used for the selection were: chloramphenicol (Cm), 4.5; kanamycin (Kan), 250; \n326 spectinomycin (Spc), 100; streptomycin (Sm), 200, gentamycin (G), 40 and erythromycin (E), \n327 0.1. Unless otherwise described, pre-competent cultures were prepared by growing cells to \n328 an OD 550nm of 0.1 in C+Y medium (pH 6.8). Then cells were 10-fold concentrated in C+Y \n329 medium supplemented with 15% glycerol and storage at –80°C.\n330 Deletion and invalidation mutagenesis.\n331 Deletion or invalidation mutagenesis was based on strand overlap extension (SOE) [51]. \n332 Briefly, primers MP170 and MP173 were used to generate PCR fragments carrying \n333 spectinomycin or kanamycin resistance gene from plasmids pr412 (SpcR) or pr413 (KanR) \n334 previously described [52]. The two PCR fragments that flank the integration site of the \n335 resistance gene were amplified with the specific primer pairs described in the supporting \n336 tables file. These pairs are composed of a primer defining the integration site and carrying the \n337 sequence complementary to MP170 or MP173 in its 5' region and a distal primer at around 1 \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n338 to 2 kb. The three PCR amplified fragments were purified and used as template to produce a \n339 unique PCR fragment using the two distal primers. The resulting fragment was used to \n340 transform a recipient strain as described above. The transformed strains were selected by \n341 appropriate antibiotic selection and sequenced (Eurofins genomics).\n342 IPTG-dependent expression platform construction.\n343 SOE was also used to generate expression platforms CEPlac- spr1630, CEPlac spr1629 or \n344 CEPlac-spr1630-1629. Primers pairs MB293-MB294 and MB295-MB291 were used to amplify \n345 an expression platform from strain R3833 previously described [28]. Internal PCR fragments \n346 carrying genes of interest were amplified from R800 strain using the following primers pairs \n347 MB296-MB297 (spr1629-1630), MB296-MB298 (spr1630), and MB299-MB297 (spr1629). Each \n348 of these fragments was used with MB293-MB294 and MB295-MB291 primer pairs as \n349 templates to generate a unique PCR fragment with primers MB293 and MB291. This final \n350 fragment was used to transform strains of interest as described above (kanamycin selection). \n351 The PcepII-lac platform was generated by transferring the Pcep-lac platform to the cpsN locus. \n352 Briefly, MM56 and MM57 were used to amplify the platform from strain R5139. Flanking cpsN \n353 loci were amplified using YA09-MM58 et YA14-MM59 primer pairs with R4631 strain as a \n354 template [53]. These three PCR fragments were used as templates to amplify a single PCR \n355 fragment using primers YA09-YA14. This fragment was used to transform strain R5198. \n356 CRISPRi depletion\n357 Strains carrying the CRISPRi system were constructed as described previously [24]. Plasmids \n358 carrying lacI repressor (pPEPY-PF6-lacI ), Cas9 enzyme (pJWV102-PL-dCas9) and expressing \n359 interfering sgRNA (pPEPX-P3-sgRNAluc) were purchased from addgene. Plasmids pPEPX-P3-\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n360 sgRNA clpX and pPEPX-P3-clpP  were constructed using the In-Fusion HD cloning kit (Takara) \n361 as previously described [24]. Primers OIM134 and OIM135 were used to amplify pPEPX-P3-\n362 sgRNA backbone. Primers pairs used to generate the RNA guide, MB551-MB552 (clpX), MM54-\n363 MM55 (clpP), were published previously [24]. Generated plasmids were sequentially \n364 integrated into the genome of strain R800 by transformation and homologous recombinaison.\n365 Monitoring of growth and luciferase expression.\n366 For monitoring operon comCDE expression, a transcriptional fusion was used, inserting a \n367 S. pneumoniae comCDE promoter fragment (HindIII - BamHI) upstream of the luc gene and \n368 carried by pR414 plasmid. Homology-dependent integration of the non-replicative \n369 recombinant plasmid into the pneumococcal chromosome was selected using erythromycin \n370 resistance [52].\n371 For the monitoring of growth and luciferase expression, precultures were gently thawed and \n372 aliquots were inoculated (unless otherwise described) at OD 550nm of 0.005 in luciferin-\n373 containing C+Y medium (pH 7) as previously described [50] and distributed into a 96-wells \n374 (300 µl per well) white microplate with clear bottom (Corning). Relative luminescence units \n375 (RLU) and OD492nm values were recorded at defined time points throughout incubation at 37°C \n376 in a Varioskan luminometer (ThermoFisher).\n377 DnaN error prone PCR and screening.\n378 DnaN locus was amplified from R800 genomic DNA using primers MB313 and MB314 and \n379 DreamTaq DNA Polymerase (thermoFisher scientific) as recommended by the supplier with or \n380 without adding 25µM of MnCl 2 to reduce the fidelity of the enzyme. The resulting fragments \n381 were used to transform strain R5086 as described above. After an incubation of 120min in CAT \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n382 medium at 37°C, transformant cells were plated and grown 24 hours on CAT agar \n383 supplemented with 4% horse blood and 20µM IPTG. DnaN locus was amplified on potential \n384 suppressor clones using primers MB313 and MB314 and a high-fidelity DNA polymerase, \n385 Primestar max DNA polymerase (Takara). PCR fragments were used to transform R5086 as \n386 previously described to confirm that suppressive mutations were linked to DnaN locus. \n387 Relevant PCR fragments were sequenced (Eurofins genomics).\n388 3D mapping of suppressive mutations on DnaN. \n389 Suppressive mutations were positioned on 3D DnaN structure from Protein Data Bank (PDB), \n390 www.pdb.org (PDB ID code 2AWA) using Pymol software V0.99.\n391 Yeast Two hybrid.\n392 Gene-coding sequences of S. pneumoniae  Spr1630 and DnaN proteins were PCR amplified \n393 using R1501 DNA as template, and inserted in Gal4-based plasmids, PGAD-C1 and PGBD-C1 \n394 [54], using the In-Fusion HD cloning kit (Takara). Primers used were MM30 and MM31 \n395 (Spr1630), MM28 and MM29 (DnaN) and OCN424 and OCN425 (PGAD-C1 and PGBD-C1).\n396 Resulting plasmids were then transformed independently in the yeast strains PJ69-4a and \n397 PJ69-4α. Saccharomyces cerevisiae cells expressing S. pneumoniae proteins as GAL4 Binding \n398 Domain (BD) fusions were mated with cells expressing some of these proteins as GAL4 \n399 Activating Domain (AD) fusions. Binary interactions were identified by growth of diploid cells \n400 after 8 or 20 days at 30°C on synthetic complete medium [55] lacking leucine, uracil and \n401 histidine (to select expression of the HIS3 interaction reporter). Controls with empty vector \n402 plasmids (i.e., carrying only the BD or AD domain) were systematically included.\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n403 Mixed culture Assay\n404 Strains R5204 and R5086 were inoculated at 0.04 OD 550nm in C+Y medium and grown in the \n405 presence of 80 µM of IPTG for 120 minutes. In parallel R825 strain was inoculated at 0.04 \n406 OD550nm in C+Y medium (pH 7) and grown for 60 minutes. Cells R5204 or R5086 were mixed \n407 with R825 (volume to volume) to an expected ratio of 1 to 1. R825 luciferase activity was then \n408 monitored. PCR amplified DNA carrying rpsL41 allele (Streptomycin resistance) was added at \n409 the time of mixing. 100 minutes after mixing a culture sample was collected and plated on \n410 agar medium supplemented with erythromycin and streptomycin to determine the \n411 percentage of transformation of strain R825. \n412 Statistical tests:\n413 Pairwise comparisons were done with a nonparametric MannWhitney test. P values were \n414 displayed as follows: ***, 0.0001 < P < 0.001; **, 0.001< P < 0.01; *, 0.01 < P < 0.05; ns, \n415 P > 0.05.\n416 Acknowledgements.\n417 We would like to extend our special thanks to Calum Johnston and Hélène Cordier for their \n418 critical review of the manuscript.\n419 References.\n420 1. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. The Lancet. 2015;386: 1097–\n421 1108. doi:10.1016/S0140-6736(15)60733-4\n422 2. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O’Brien KL. The fundamental link between \n423 pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11: 841–855. \n424 doi:10.1586/erv.12.53\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n425 3. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of \n426 bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399: 629–\n427 655. doi:10.1016/S0140-6736(21)02724-0\n428 4. Straume D, Stamsås GA, Håvarstein LS. Natural transformation and genome evolution in \n429 Streptococcus pneumoniae. Infect Genet Evol. 2015;33: 371–380. \n430 doi:10.1016/j.meegid.2014.10.020\n431 5. Griffith F. The Significance of Pneumococcal Types. Epidemiol Infect. 1928;27: 113–159. \n432 doi:10.1017/S0022172400031879\n433 6. Avery OT, MacLeod CM, McCarty M. STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE \n434 INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION \n435 BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III. J Exp \n436 Med. 1944;79: 137–158. doi:10.1084/jem.79.2.137\n437 7. Johnston C, Campo N, Bergé MJ, Polard P, Claverys J-P. Streptococcus pneumoniae, le \n438 transformiste. Trends Microbiol. 2014;22: 113–119. doi:10.1016/j.tim.2014.01.002\n439 8. Claverys J-P, Martin B, Polard P. The genetic transformation machinery: composition, \n440 localization, and mechanism. FEMS Microbiol Rev. 2009;33: 643–656. doi:10.1111/j.1574-\n441 6976.2009.00164.x\n442 9. Dubnau D, Blokesch M. Mechanisms of DNA Uptake by Naturally Competent Bacteria. Annu Rev \n443 Genet. 2019;53: 217–237. doi:10.1146/annurev-genet-112618-043641\n444 10. Håvarstein LS, Coomaraswamy G, Morrison DA. An unmodified heptadecapeptide pheromone \n445 induces competence for genetic transformation in Streptococcus pneumoniae. Proc Natl Acad \n446 Sci U S A. 1995;92: 11140–11144. \n447 11. Pestova EV, Håvarstein LS, Morrison DA. Regulation of competence for genetic transformation \n448 in Streptococcus pneumoniae by an auto-induced peptide pheromone and a two-component \n449 regulatory system. Mol Microbiol. 1996;21: 853–862. \n450 12. Ween O, Gaustad P, Håvarstein LS. Identification of DNA binding sites for ComE, a key regulator \n451 of natural competence in Streptococcus pneumoniae. Mol Microbiol. 1999;33: 817–827. \n452 13. Dagkessamanskaia A, Moscoso M, Hénard V, Guiral S, Overweg K, Reuter M, et al. \n453 Interconnection of competence, stress and CiaR regulons in Streptococcus pneumoniae: \n454 competence triggers stationary phase autolysis of ciaR mutant cells. Mol Microbiol. 2004;51: \n455 1071–1086. \n456 14. Peterson SN, Sung CK, Cline R, Desai BV, Snesrud EC, Luo P, et al. Identification of competence \n457 pheromone responsive genes in Streptococcus pneumoniae by use of DNA microarrays. Mol \n458 Microbiol. 2004;51: 1051–1070. \n459 15. Prudhomme M, Berge M, Martin B, Polard P. Pneumococcal Competence Coordination Relies \n460 on a Cell-Contact Sensing Mechanism. PLoS Genet. 2016;12. doi:10.1371/journal.pgen.1006113\n461 16. Prudhomme M, Johnston CHG, Soulet A-L, Boyeldieu A, De Lemos D, Campo N, et al. \n462 Pneumococcal competence is a populational health sensor driving multilevel heterogeneity in \n463 response to antibiotics. Nat Commun. 2024;15: 5625. doi:10.1038/s41467-024-49853-2\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n464 17. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys J-P. Antibiotic stress induces genetic \n465 transformability in the human pathogen Streptococcus pneumoniae. Science. 2006;313: 89–92. \n466 doi:10.1126/science.1127912\n467 18. Domenech A, Slager J, Veening J-W. Antibiotic-Induced Cell Chaining Triggers Pneumococcal \n468 Competence by Reshaping Quorum Sensing to Autocrine-Like Signaling. Cell Rep. 2018;25: \n469 2390-2400.e3. doi:10.1016/j.celrep.2018.11.007\n470 19. Slager J, Kjos M, Attaiech L, Veening J-W. Antibiotic-induced replication stress triggers bacterial \n471 competence by increasing gene dosage near the origin. Cell. 2014;157: 395–406. \n472 doi:10.1016/j.cell.2014.01.068\n473 20. Maziero M, Lane D, Polard P, Bergé M. Fever-like temperature bursts promote competence \n474 development via an HtrA-dependent pathway in Streptococcus pneumoniae. PLoS Genet. \n475 2023;19: e1010946. doi:10.1371/journal.pgen.1010946\n476 21. Luo P, Li H, Morrison DA. ComX is a unique link between multiple quorum sensing outputs and \n477 competence in Streptococcus pneumoniae. Mol Microbiol. 2003;50: 623–633. \n478 22. Stevens KE, Chang D, Zwack EE, Sebert ME. Competence in Streptococcus pneumoniae is \n479 regulated by the rate of ribosomal decoding errors. mBio. 2011;2. doi:10.1128/mBio.00071-11\n480 23. Chastanet A, Prudhomme M, Claverys JP, Msadek T. Regulation of Streptococcus pneumoniae \n481 clp genes and their role in competence development and stress survival. J Bacteriol. 2001;183: \n482 7295–7307. doi:10.1128/JB.183.24.7295-7307.2001\n483 24. Liu X, Gallay C, Kjos M, Domenech A, Slager J, van Kessel SP, et al. High-throughput CRISPRi \n484 phenotyping identifies new essential genes in Streptococcus pneumoniae. Mol Syst Biol. \n485 2017;13. doi:10.15252/msb.20167449\n486 25. Robertson GT, Ng W-L, Gilmour R, Winkler ME. Essentiality of clpX, but not clpP, clpL, clpC, or \n487 clpE, in Streptococcus pneumoniae R6. J Bacteriol. 2003;185: 2961–2966. \n488 doi:10.1128/JB.185.9.2961-2966.2003\n489 26. Piotrowski A, Burghout P, Morrison DA. spr1630 is responsible for the lethality of clpX \n490 mutations in Streptococcus pneumoniae. J Bacteriol. 2009;191: 4888–4895. \n491 doi:10.1128/JB.00285-09\n492 27. Martin B, Granadel C, Campo N, Hénard V, Prudhomme M, Claverys J-P. Expression and \n493 maintenance of ComD-ComE, the two-component signal-transduction system that controls \n494 competence of Streptococcus pneumoniae. Mol Microbiol. 2010;75: 1513–1528. \n495 doi:10.1111/j.1365-2958.2010.07071.x\n496 28. Johnston C, Mortier-Barriere I, Khemici V, Polard P. Fine-tuning cellular levels of DprA ensures \n497 transformant fitness in the human pathogen Streptococcus pneumoniae. Mol Microbiol. \n498 2018;109: 663–675. doi:10.1111/mmi.14068\n499 29. van Opijnen T, Bodi KL, Camilli A. Tn-seq: high-throughput parallel sequencing for fitness and \n500 genetic interaction studies in microorganisms. Nat Methods. 2009;6: 767–772. \n501 doi:10.1038/nmeth.1377\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n502 30. Wuchty S, Rajagopala SV, Blazie SM, Parrish JR, Khuri S, Finley RL, et al. The Protein Interactome \n503 of Streptococcus pneumoniae and Bacterial Meta-interactomes Improve Function Predictions. \n504 mSystems. 2017;2. doi:10.1128/mSystems.00019-17\n505 31. Simonsen S, Søgaard CK, Olsen JG, Otterlei M, Kragelund BB. The bacterial DNA sliding clamp, β-\n506 clamp: structure, interactions, dynamics and drug discovery. Cell Mol Life Sci CMLS. 2024;81: \n507 245. doi:10.1007/s00018-024-05252-w\n508 32. Piotrowski A, Luo P, Morrison DA. Competence for genetic transformation in Streptococcus \n509 pneumoniae: termination of activity of the alternative sigma factor ComX is independent of \n510 proteolysis of ComX and ComW. J Bacteriol. 2009;191: 3359–3366. doi:10.1128/JB.01750-08\n511 33. Calvo-Villamañán A, Ng JW, Planel R, Ménager H, Chen A, Cui L, et al. On-target activity \n512 predictions enable improved CRISPR–dCas9 screens in bacteria. Nucleic Acids Res. 2020;48: \n513 e64. doi:10.1093/nar/gkaa294\n514 34. Bose B, Auchtung JM, Lee CA, Grossman AD. A conserved anti-repressor controls horizontal \n515 gene transfer by proteolysis. Mol Microbiol. 2008;70: 570–582. doi:10.1111/j.1365-\n516 2958.2008.06414.x\n517 35. Bose B, Grossman AD. Regulation of horizontal gene transfer in Bacillus subtilis by activation of \n518 a conserved site-specific protease. J Bacteriol. 2011;193: 22–29. doi:10.1128/JB.01143-10\n519 36. Millman A, Melamed S, Leavitt A, Doron S, Bernheim A, Hör J, et al. An expanded arsenal of \n520 immune systems that protect bacteria from phages. Cell Host Microbe. 2022;30: 1556-1569.e5. \n521 doi:10.1016/j.chom.2022.09.017\n522 37. Texier P, Bordes P, Nagpal J, Sala AJ, Mansour M, Cirinesi A-M, et al. ClpXP-mediated \n523 Degradation of the TAC Antitoxin is Neutralized by the SecB-like Chaperone in Mycobacterium \n524 tuberculosis. J Mol Biol. 2021;433: 166815. doi:10.1016/j.jmb.2021.166815\n525 38. Lehnherr H, Yarmolinsky MB. Addiction protein Phd of plasmid prophage P1 is a substrate of \n526 the ClpXP serine protease of Escherichia coli. Proc Natl Acad Sci U S A. 1995;92: 3274–3277. \n527 doi:10.1073/pnas.92.8.3274\n528 39. Prysak MH, Mozdzierz CJ, Cook AM, Zhu L, Zhang Y, Inouye M, et al. Bacterial toxin YafQ is an \n529 endoribonuclease that associates with the ribosome and blocks translation elongation through \n530 sequence-specific and frame-dependent mRNA cleavage. Mol Microbiol. 2009;71: 1071–1087. \n531 doi:10.1111/j.1365-2958.2008.06572.x\n532 40. Khemici V, Prudhomme M, Polard P. Tight Interplay between Replication Stress and \n533 Competence Induction in Streptococcus pneumoniae. Cells. 2021;10: 1938. \n534 doi:10.3390/cells10081938\n535 41. López de Saro FJ, O’Donnell M. Interaction of the beta sliding clamp with MutS, ligase, and DNA \n536 polymerase I. Proc Natl Acad Sci U S A. 2001;98: 8376–8380. doi:10.1073/pnas.121009498\n537 42. Bernard P, Couturier M. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-\n538 topoisomerase II complexes. J Mol Biol. 1992;226: 735–745. doi:10.1016/0022-2836(92)90629-\n539 x\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n540 43. Jiang Y, Pogliano J, Helinski DR, Konieczny I. ParE toxin encoded by the broad-host-range \n541 plasmid RK2 is an inhibitor of Escherichia coli gyrase. Mol Microbiol. 2002;44: 971–979. \n542 doi:10.1046/j.1365-2958.2002.02921.x\n543 44. LeRoux M, Laub MT. Toxin-Antitoxin Systems as Phage Defense Elements. Annu Rev Microbiol. \n544 2022;76: 21–43. doi:10.1146/annurev-micro-020722-013730\n545 45. Aakre CD, Phung TN, Huang D, Laub MT. A Bacterial Toxin Inhibits DNA Replication Elongation \n546 Through a Direct Interaction with the β  Sliding Clamp. Mol Cell. 2013;52: 617–628. \n547 doi:10.1016/j.molcel.2013.10.014\n548 46. Charpentier X, Polard P, Claverys J-P. Induction of competence for genetic transformation by \n549 antibiotics: convergent evolution of stress responses in distant bacterial species lacking SOS? \n550 Curr Opin Microbiol. 2012;15: 570–576. doi:10.1016/j.mib.2012.08.001\n551 47. Gasc AM, Sicard N, Claverys JP, Sicard AM. Lack of SOS repair in Streptococcus pneumoniae. \n552 Mutat Res. 1980;70: 157–165. \n553 48. Ernits K, Saha CK, Brodiazhenko T, Chouhan B, Shenoy A, Buttress JA, et al. The structural basis \n554 of hyperpromiscuity in a core combinatorial network of type II toxin-antitoxin and related \n555 phage defense systems. Proc Natl Acad Sci U S A. 2023;120: e2305393120. \n556 doi:10.1073/pnas.2305393120\n557 49. Lefevre JC, Claverys JP, Sicard AM. Donor deoxyribonucleic acid length and marker effect in \n558 pneumococcal transformation. J Bacteriol. 1979;138: 80–86. \n559 50. Martin B, Prudhomme M, Alloing G, Granadel C, Claverys JP. Cross-regulation of competence \n560 pheromone production and export in the early control of transformation in Streptococcus \n561 pneumoniae. Mol Microbiol. 2000;38: 867–878. \n562 51. Horton RM. PCR-mediated recombination and mutagenesis. SOEing together tailor-made \n563 genes. Mol Biotechnol. 1995;3: 93–99. doi:10.1007/BF02789105\n564 52. Bergé M, Moscoso M, Prudhomme M, Martin B, Claverys J-P. Uptake of transforming DNA in \n565 Gram-positive bacteria: a view from Streptococcus pneumoniae. Mol Microbiol. 2002;45: 411–\n566 421. \n567 53. Johnston CHG, Hope R, Soulet A-L, Dewailly M, De Lemos D, Polard P. The RecA-directed \n568 recombination pathway of natural transformation initiates at chromosomal replication forks in \n569 the pneumococcus. Proc Natl Acad Sci U S A. 2023;120: e2213867120. \n570 doi:10.1073/pnas.2213867120\n571 54. James P, Halladay J, Craig EA. Genomic libraries and a host strain designed for highly efficient \n572 two-hybrid selection in yeast. Genetics. 1996;144: 1425–1436. \n573 doi:10.1093/genetics/144.4.1425\n574 55. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. \n575 (Academic Pr, 1998). 1998. \n576\n577 Figure Legends.\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n578 Fig. 1: Depletion of clpX or clpP induces competence. \n579 A. comCDE expression was monitored in strains carrying CRISPRi guide RNA targeting clpX \n580 R4993 (left) or clpP R5203 (right). Cells were grown in C+Y medium at 37°C with or without \n581 IPTG, as shown in the colour key. Culture was initiated 100 minutes prior to the first \n582 measurement at time 0. comCDE expression values are expressed in relative light units per \n583 OD (RLU/OD) in the top panel and the corresponding growth curves are reported as OD492nm \n584 in the bottom panel.\n585 B. Identical to A in ripA strains carrying CRISPRi guide RNA targeting respectively 4995 (clpX \n586 depletion, left) and R5250 (clpP, right). \n587 For the sake of clarity, only a single data set, representative of at least three independent \n588 experiments carried out on different days, is presented.\n589\n590 Fig 2: ripA expression induces competence development \n591 A. Schematic representation of ripA-ripB locus and its chromosomal surroundings.\n592 B. comCDE expression was monitored in strains expressing ripA (R5139), ripB (R5138) or ripA-\n593 ripB (R5140) under the control of an IPTG inducible promotor. Cells were grown in C+Y \n594 medium at 37°C with increasing concentration of IPTG from the first measurement at time 0. \n595 Top panels: luciferase activity expressed in relative light units per OD (RLU/OD). Bottom \n596 panels: corresponding growth curves. \n597\n598 Fig 3: Trans-dependant suppression of RipA toxicity by RipB.\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n599 A. Strains expressing ripA (R5139), ripB (R5138) or ripA-ripB (R5140) under the control of an \n600 IPTG inducible promotor were serially diluted and spotted on CAT agar supplemented with 4% \n601 horse blood containing different concentrations of IPTG. Plates were incubated at 37 °C \n602 overnight. \n603 For clarity, only a single spot test is presented and also represented as a histogram form in B \n604 to reflect the efficiency of plating. Three independent spot tests were carried out on different \n605 days displaying same results.\n606 C. Same as B. for strains expressing ripA under the control of CepIIlac IPTG inducible promotor \n607 at the cps locus (see material and methods), (R5239 and R5259). In strain R5259, ripB is \n608 expressed under the control of CEPlac IPTG inducible promotor at the“ami locus”.\n609 D. Percentage of transformation of strain wild type (wt) (R800) or invalidated for ripA (R4796) \n610 with DNA carrying ripB invalidation (spectinomycin insertion). In the control, these two strains \n611 were transformed with DNA carrying a point mutation conferring resistance to \n612 streptomycin(rpsl41).\n613 Fig 4: Mutations in DnaN confer different levels of resistance to RipA toxicity. \n614 A. Strain R5086, expressing ripA under the control of an IPTG inducible promotor was transformed \n615 with different error prone PCR fragments amplified from dnaN locus (see material and methods). \n616 Transformant cells were plated on CAT agar supplemented with 4% horse blood containing 20µM \n617 IPTG. CFU were numerated after overnight incubation at 37 °C.\n618 B. Top panel. Schematic representation of the dnaN locus and its environment amplified by \n619 primers MB313 and MB314. Red vertical lines indicate the position of mutated residues that \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n620 supress RipA toxicity. Positioning of the different suppressive mutations on the primary \n621 structure (middle panel) and on the tertiary 3D structure of DnaN (bottom panel). \n622 C. Efficiency of plating of strains expressing ripA under the control of an IPTG inducible \n623 promotor in a dnaN wild type genetic background (R5139) or in a DnaN suppressor mutations \n624 genetic background (R5165 to R5171). The strain expressing ripA-ripB under the control of \n625 IPTG was used as a growth control (R5140). Cells were plated on CAT agar supplemented with \n626 4% horse blood containing different concentrations of IPTG. For clarity, only a single spot test \n627 is presented as a histogram. Three independent determinations were made on different days \n628 displaying same results.\n629\n630 Fig 5: Suppressor mutations in DnaN reduce interactions with RipA in Yeast-\n631 two-hybrid system. \n632 A. Yeast-two-hybrid matrices produced to test interactions between RipA and DnaN. \n633 B. Yeast-two-hybrid matrices performed to test interactions between RipA and DnaN \n634 suppressive alleles.\n635\n636 Fig 6: Suppressor mutations in DnaN impair RipA dependant competence \n637 development.\n638 A. comCDE  expression was monitored in strains expressing ripA under the control of an IPTG inducible \n639 promotor in a wild type dnaN genetic background (R5138) or in strains carrying suppressive alleles of \n640 dnaN, H183P (R5167), L185R (R5168), Y249N (R5169). Cells were grown in C+Y medium at 37°C with \n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n641 increasing amounts of IPTG from the first measurement at time 0. Top panels: luciferase activity \n642 expressed in relative light units per OD (RLU/OD). Bottom panels: corresponding growth curves. \n643 B. zoom in on transcription induction curves (A) in strains carrying suppressor mutations.\n644 Fig 7: RipA toxicity allows propagation of competence to naive cells.\n645 A. Phase contrast time-lapses of the strain expressing ripA under the control of an IPTG \n646 inducible promotor (R5139) without or with 80µM of IPTG (respectively top and bottom \n647 panels).\n648 B. Ability of R5139 strain to generate colony after IPTG exposure. R5204 strain was exposed \n649 or not to 80µM of IPTG for different times (X-axis), washed with fresh medium and plated on \n650 Agar medium without IPTG.\n651 C. Responsiveness of R5139 strain to CSP after one hour exposition or not to IPTG.\n652 D. Mixed culture of strains expressing ripA under the control of an IPTG inducible promotor, \n653 R5204 (comC+) or R5086 (comC0), with R825 strain used as competence reporter cells \n654 through its PcomCDE::luc construct. Top panels: luciferase activity of R825 strain alone (grey) \n655 or mixed with R5204 (red) or R5086 (blue). Middle panels: corresponding growth curves. For \n656 clarity, only a single data set, representative of at least three independent determinations \n657 made on different days, is presented.\n658 Bottom panel. R825 transformation frequency that occurs during mixed cultures.\n659 Fig 8: Working model of RipA action on competence development at single cell \n660 and population level in S. pneumoniae.\n661\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint \n\n.CC-BY 4.0 International licenseperpetuity. It is made available under a \npreprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in \nThe copyright holder for thisthis version posted September 2, 2025. ; https://doi.org/10.1101/2025.09.02.673660doi: bioRxiv preprint","source_license":"CC-BY-4.0","license_restricted":false}